{"title":"NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study","link":"https://www.sciencedirect.com/science/article/pii/S2405844024155673?dgcid=rss_sd_all","date":null,"content":"<p>Publication date: 30 October 2024</p><p><b>Source:</b> Heliyon, Volume 10, Issue 20</p><p>Author(s): Dániel Sandi, Zsófia Kokas, Zsigmond Tamás Kincses, Judit Füvesi, Zsanett Fricska-Nagy, Erika Vörös, Tamás Biernacki, László Vécsei, Péter Klivényi, Krisztina Bencsik</p>","author":"","siteTitle":"ScienceDirect Publication: Heliyon","siteHash":"f7bd7e3f1869707615b3e54fb4ebc4eb7c817c729fd5ad33a7fd4ed65328d468","entryHash":"3c7e81274beae7a4c2c3e8467daa2ffb8236656ee70f6e4645e5dd6063285b5e","category":"Interdisciplinary"}